Welcome to the Abstract Submission Website for
the MACULART Meeting 2025
SUBMISSION OF ABSTRACTS IS NOW OPEN!
OPEN FOR SUBMISSION OF ABSTRACTS !
EXTENDED DEADLINE FOR SUBMISSIONS : June 15th, 2020
Important dates
October 14, 2024 -
Opening of Abstract Submission
Deccember 9, 2024 - Opening of Clinical Case Submission
April, 16, 2025 -
Deadline for Abstract Submission and Clinical Case Submission
May 12, 2025 -
Result Annoucement
Mid-May, 2025 - Opening of a second phase of "Late breaking news" submissions
Getting started
It is simple to set up your personal account and submit your abstract!
First of all, click on the button below marked 'Click here for your first connexion' and follow the steps:
1- Enter your email address. It will be used to log into your personal account each time you visit the website.
2- Create your password. Your password should be easy for you to remember, something personal and at least 8 characters long.
3- Enter your personal information. All boxes with * are mandatory information and you will not be able to save your details unless these are completed.
A summary of your account information will appear on the screen. To finalise the procedure, please be sure to click on 'Create Account', otherwise your information will not be saved.
Please remember your login name and password! You will need them later to log into the system after a decision has been made for your abstract.
Information will be sent only to the « contact author », to the e-mail address registered on login. This is why we recommend you provide the contact details of the presenting author when creating your author account.
Submission guidelines
Before submitting your abstract, thank you for paying attention to the following guidelines:
=> Your abstract must be submitted in
ENGLISH and not exceed
300 words
=> It will have to be allocated to a
specific category:
- Prevention of AMD
- Fibrosis
- AI & Retina
- Geography Atrophy
- Macula Imaging
- Neovascular AMD
- Diabetes
- Macular Surgery
- Vein Occlusion
- New therapeutic approaches
- Gene Therapy
- Myopia / Uveitis
=> The abstract must respect the following framework:
- Objective
- Material & Methods
- Results
- Conclusions
=>
Simple tables, graphs and pictures are allowed.
In order to avoid problems of incompatibility, we ask you to prepare your text with the Arial font, size 10. The text must be single space and a single paragraph starting without any indentation.
Then, you will have to copy and paste the text (without the title and the list of authors) in the indicated field for this purpose using the appropriate icon
.
Title and author’s names will have to be typed out in separate fields.
Publication
All accepted abstracts will be published in the framework of the congress on the website.
The Contributor guarantees that the content of his /her Contribution is compliant with the law and does not breach any rights of third parties (such as copyrights, images, obligation of confidentiality notably), either because he/she is the owner of the rights on all the components included in his/her Contribution, or because these components are free of any rights, or because he/she has obtained the express authorization of the relevant third parties.
The Contributor undertakes to ensure with the utmost care the accuracy of the information he/she provides.
The Contributor alone shall be the liable for the content of his/her Contribution and undertakes to guarantee Europa should the liability of Europa come to be incurred by a third party because of the content of the Contribution.
When including pictures in your presentation, please beware when sourcing them from internet. They are generally not free of rights and can expose you to financial penalties (€1,500 per image) from their authors.
Modifications
You can modify your abstract until the submission deadline.
No changes to the abstract will be possible once the submission deadline has passed.
If necessary send an e-mail to:
support-maculart@europa-organisation.com
Selection process
Abstracts will be considered for
oral presentation or
poster presentation.
Results will be sent by email to the author who submitted the abstract.
Registration
The acceptance of an abstract does not mean free-of-charge participation. Registration, travel and accommodation will remain at the charge of abstract presenters.
You will find more information directly on the congress website:
https://www.maculart.fr
For any questions about your registration, please contact our registration department:
maculart@europa-organisation.com